title: [Novel agents for antithrombotic therapy in cardiology].
abstract: Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The "gold constant" combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.
authors.affiliation: MH Honvédkórház Kardiológiai Osztály Budapest Róbert Károly krt. 44. 1134. robertgaborkiss@gmail.com
authors.forename: Róbert Gábor
authors.initials: RG
authors.lastname: Kiss
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D003374:Coumarins / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin